Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0034063 (
pulmonary edema
)
10,665
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
placental alkaline phosphatase
(
PLAP
) is a marker enzyme of alveolar type I cells. To evaluate the damages of alveolar type I cells and its relations with the development of acute lung injury caused by smoke inhalation, the present study was designed to observe the dynamic changes in
PLAP
contents in plasma and bronchoalveolar lavage fluid (BALF). Following the induction of smoke inhalation injury in rat, the arterial blood gas levels, lung water volume, total protein and albumin contents in BALF, and
PLAP
contents in plasma and BALF were determined respectively in normal control and injured animals at 2, 6, 12 and 24 h after injury. The pathomorphology of lung tissues was also observed. It was found that after smoke inhalation, animals showed acute respiratory failure and serious
pulmonary edema
. The total protein and albumin levels in BALF increased markedly. Both
PLAP
contents in plasma and BALF also increased dramatically, and there was a significant positive correlation between the changes in the
PLAP
and the total protein contents in BALF. The pathomorphologically serious structural damage of alveolar type I cells were also found.
PLAP
may be not only a marker of alveolar type I cells injury, but also interrelated with the permeability increase of alveolar-capillary membrane after smoke inhalation.
...
PMID:[Determination of placental alkaline phosphatase (PLAP) for detecting the damages of alveolar type I cells caused by smoke inhalation]. 938 32